|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0769 EUR | +2.12% |
|
+0.79% | +17.94% |
| Mar. 09 | TME Pharma N.V. Extends Maturity of EUR 2.06 Million Loans and Announces Early Redemption of EUR 163,562.50 Bonds | CI |
| Mar. 09 | TME Pharma Secures 12-month Loan Extension | MT |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 19.67K | - | -27,636.84% | - | - | 0.61x | |
| 7.25B | 9.67% | 17.9% | 6.77% | 3.48% | 1.5x | |
| 5.34B | 5.37% | 8.37% | 11.07% | 4.42% | -3.99x | |
| 2.41B | 11.88% | 13.83% | 2.46% | 2.14% | 1.28x | |
| 16.31B | 8.34% | 13.38% | 32.9% | 4.79% | 3.63x | |
| 846M | -31.67% | -18.92% | - | - | 1.57x | |
| 2.53B | 17.83% | 20.93% | 70.23% | 22.13% | -0.89x | |
| 8.57B | 6.51% | 14.79% | 11.46% | 4.17% | 2.2x | |
| 944M | -40.36% | -40.47% | -70.72% | -11.67% | 5.33x | |
| 12.94M | -1,409.6% | -1,383.2% | -148.95% | - | 0.4x | |
| 1.27B | -19.27% | -3.71% | -38.64% | -6.61% | -65.61x | |
| 509M | -13.19% | -41.67% | -31.26% | -21.6% | -0.14x | |
| 1.98B | 4.23% | 28.66% | 13.31% | 8.32% | 0.34x | |
| 1.22B | 6.02% | 31.45% | 15.37% | 11.65% | 0.43x | |
| 4.02B | -3.59% | 19.77% | 15.46% | 6.99% | 1.98x | |
| 8.28B | 9.56% | 19.29% | 12.39% | 6.87% | 1.66x | |
| 1.68B | 14.61% | 17.14% | 13.7% | 7.12% | 1.33x | |
| Average | 3.72B | -88.98% | -1,701.13% | -5.63% | 3.01% | -2.84x | |
| Weighted average by Cap. | 5.28B | -52.41% | -46.11% | 1.37% | 3.35% | -1.51x |
- Stock Market
- Equities
- ALTME Stock
- Sector TME Pharma N.V.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
